Jenike MA: Handbook of Geriatric Psychopharmacology. Littleton Mass , PSG Publishing Co Inc, 1985 .
2.
Jenike MA: MAO inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease). Am J Psychiatry1985;142:763-764.
3.
Gurland BJ: The comparative frequency of depression in various adult age groups . J Gerontol1976;31:283-292.
4.
Anonymous: Psychiatric illness among medical patients. Lancet1979;1:479.
5.
Moffie HS, Paykel ES: Depression in medical inpatients. Br J Psychiatry1975;126:346-353.
6.
Sendbuehler J., Goldstein S.: Attempted suicide among the aged . J Am Geriatr Soc1977;25:245-248.
7.
Jefferson JW , Marshall JR: Neuropsychiatric Features of Medical Disorders . New York , Plenum Press, 1981.
8.
Kay Dwk, Bergman K.: Physical disability and mental health in old age. J Psychosom Res1966;10:3-12.
9.
Avery D., Winokur G.: Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry1976 ;33:1029-1037.
10.
Tsuang MT, Woolson RF, Fleming JA: Premature deaths in schizophrenia and affective disorders. Arch Gen Psychiatry1980;37:979-983..
11.
Jenike MA: Drug treatment of depression. Top Geriatr1983;2: 9-11.
12.
Wells CE: Pseudodementia. Am J Psychiatry1963 ;120:244-249.
13.
Wells CE: Pseudodementia. Am J Psychiatry1979 ;136:895-900.
14.
Feinberg T. , Goodman B.: Affective illness, dementia, and pseudodementia . J Clin Psychiatry1984;45:99-103.
15.
Cole JO, Branconnier R., Salomon M, et al: Tricyclic use in the cognitively impaired elderly . J Clin Psychiatry1983; September (Sec 2):14-19.
16.
Spar JE, LaRue A.: Major depression in the elderly: DSM III criteria and the dexamethasone suppression test as predictors of treatment response. Am J Psychiatry1983;140:844-847.
17.
Jenike MA: Depression in the elderly. Top Geriatrics1983;1:33.
18.
Jenike MA: Depressed in the ER. Emergency Med1984;16: 102-120.
19.
Jenike MA, Anderson WH: Depression: Emergency assessment and differential diagnosis, in Manschreck TC, Murray GB (eds): Psychiatric Medicine Update. New York, Elsevier, 1984, pp 55-71.
20.
Lazare A.: Unresolved grief, in Lazare A (ed): Outpatient Psychiatry. Baltimore, Williams & Willkins, 1979, pp 498-512.
21.
Clayton PJ: Mortality and morbidity in the first year of widowhood. Arch Gen Psychiatry1974;30:747-750.
22.
Anderson WH: Depression, in Lazare A (ed): Outpatient PsychiatryBaltimore, Williams & Wilkins, 1979; pp 257-260.
23.
Resnick H., Cantor J.: Gerifacts. Geriatrics1967; 22:68.
24.
Guggenheim FG : Suicide, in Hackett TP, Cassem NH (eds): Massachusetts General Hospital Handbook of General Hospital Psychiatry . St. Louis, CV Mosby, 1978, pp 250-263.
25.
Salzman C.: A primer on geriatric psychopharmacology. Am J Psychiatry1982;139:67-76.
26.
Neshkes RE, Gerner R., Jarvik LE, et al: Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients. J Clin Psychopharmacol1985;5:102-106.
27.
Richelson E. : Pharmacology of antidepressants in use in the United States. J Clin Psychiatry1982;43(11) (sect 2):4-11.
Tollefson GD , Senogles SE, Frey II WH, et al: A comparison of peripheral and central human muscarinic cholinergic receptor affinities for psychotropic drugs. Biol Psychiatry1982 ; 5:555-567.
30.
Dominquez RA: Evaluation the effectiveness of the new antidepressants . Hosp Community Psychiatry1983;34:405-407.
31.
Lydiard RB, Gelenberg AJ: Amoxapine: An antidepressant with some neuroleptic properites? Pharmacotherapy1981;1: 163-175.
32.
Barton JL: Amoxapine-induced agitation among bipolar depressed patients. Am J Psychiatry1982;139:387.
33.
Jenike MA: Dyskinesia associated with amoxapine (Asendin) antidepressant therapy . Top Geriatr1983;1:56.
34.
Lapierre YD , Anderson K.: Dyskinesia associated with amoxapine antidepressant therapy: A case report. Am J Psychiatry1983 ;140:493-494.
35.
Jenike MA: Tardive dyskinesia: Special risk in the elderly. J Am Geriatr Soc1983;31:71-73.
36.
Wells BG, Gelenberg AJ: Chemistry, pharmacology, pharmacokinetics, adverse effects and efficacy of the antidepressant maprotiline hydrochloride. Pharmacotherapy1981;1:121-139.
37.
Murphy JE, Ankier SI: An evaluation of trazodone in the treatment of depression. Neuropharmacology1980 ;19:1217-1218.
38.
Newton R.: The side effect profile of trazodone in comparison to an active control and placebo. J Clin Psychopharmacol1981; 1(65):895-935.
39.
Himmelhoch JM: Cardiovascular effects of trazodone in humans . J Clin Psychopharmacol1981;1(65):765-815.
40.
Quitkin FM, Rabkin JG, Ross D., et al: Duration of antidepressant drug treatment. Arch Gen Psychiatry1984;41:238-245.
41.
Task Force on the use of laboratory tests in psychiatry: Tricyclic antidepressants—blood level measurements and clinical outcome. Am J Psychaitry1985;142:142-149.
42.
Jenike MA: The use of monoamine oxidase inhibitors in elderly depressed patients . J Am Geriatr Soc1984;32:571-575.
43.
Ashford W., Ford CV: Use of MAO inhibitors in elderly patients. Am J Psychiatry1979;136:1466.
44.
Sheehan DV, Claycomb JB, Kouretas N.: Monoamine oxidase inhibitors: Prescription and patient management . Int J Psychiatry Med1980- 1981;10:99.
45.
Jenike MA: Alcohol and antihistamines not contraindicated with MAOIs?Am J Psychiatry1983;140:1107..
46.
Mitchell RS : Fatal toxic encephalitis occurring during iproniazid therapy and pulmonary tuberculosis. Ann Intern Med1955;42:417.
47.
Meyer D., Halfin V.: Toxicity secondary to meperidine in patients on monoamine oxidase inhibitors: A case report and critical review. J Clin Psychopharmacology1981;1:319.
48.
Papp C., Benaim S.: Toxic effects of iproniazid in a patient with angina. Br Med J1958;2:1070.
49.
Mielke DH: Adverse reactions to thymoleptics, in Gallant DM, Simpson GM (eds): Depression: Behavioral, Biochemical, Diagnostic and Treatment Concepts. Holliswood, NY, Spectrum Publications, 1976.
50.
Robinson DS , Nies A., Revaris CL, et al: Clinical Pharmacology of phenelzine . Arch Gen Psychiatry1978;35:629.
51.
Jenike MA: MAO inhibitors as treatment for depressed patients with primary degenerative dementia. Am J Psychiatry1985;142:763-764.
52.
Kronig MH, Roose SP, Walsh BT, et al: Blood pressure effects of phenelzine. J Clin Psychopharmacol1983;3:307.
53.
Neil JF, Licata SM, May SJ, et al: Dietary noncompliance during treatment with tranylcypromine. J Clin Psychiatry1979; 40:33-37.
54.
Davidson J. , White H.: The effect of isocarboxazid on platelet MAO activity. Biol Psychiatry1983 ;18:1075-1079.
55.
White K., MacDonald N., Razini J., et al: Compr Psychiatry1983; 24:453-457.
56.
Goodman LS, Gilman A.: The Pharmacological Basis of Therapeutics. New York, MacMillan Publishing Co Inc, 1975.
57.
Jefferson JW : Lithium and affective disorder in the elderly . Compr Psychiatry1983;24:166-178.
58.
Roth M.: The natural history of mental disorder in old age. J Ment Sci1955;101:281-301.
59.
Angst J., Baastrup P., Grof P., et al: The course of monopolar depression and bipolar psychoses. Psychiatr Neurol Neurochir1973;76:489-500.
60.
Dunner DL, Roose SP, Bone S.: Complications of lithium treatment in older patients, in Geshon S, Kline NS, Shou M (eds): Lithium Controversies and Unresolved Issues. Amsterdam, Excerpta Medica , 1979, pp 427-431.
61.
DeMontigny C., Grunberg F., Mayer A., et al: Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders . Br J Psychiatry1981;138:252-256.
62.
Rowe JW, Andres R., Tobin JD, et al: The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol1976;31:155-163.
63.
Himmelhoch JM, Neil JF, May SJ, et al; Age, dementia, dyskinesias, and lithium response. Am J Psychiatry1980;137: 941-945.
64.
Jefferson JW , Greist JH: Primer of Lithium Therapy. Baltimore, Williams & Wilkins Co, 1977.
65.
Reimann IW, Frolich JC: Effects of diclofenac on lithium kinetics. Clin Pharmacol Ther1981;30:348-352.
66.
Krauthammer C. , Klerman GL: Secondary mania. Arch Gen Psychiatry1978;35:1333-1339.
67.
Liptzin B.: Treatment of mania, in Salzman C (ed): Clinical Geriatric Psychopharmacology. New York, McGraw-Hill Book Co, 1984, pp 116-131.
68.
Foster JR, Rosental JS: Lithium treatment of the elderly, Johnson FN (ed): Handbook of Lithium Therapy. Lancaster, England , MTP Press, 1980, pp 414-420.
69.
Judd LL, Hubbard B., Janowsky DS, et al: The effect of lithium carbonate on the cogntive functions of normal subjects. Arch Gen Psychiatry1977;34:355-357.
70.
Makeeva VL, Gol'davskach IL, Pozdnyakova SL: Somatic changes and side effects from the us of lithium salts in the prevention of affective disorders. Ah Neuropatol Psikhiatr1974;74:602-607.
71.
Myerson A.: The effect of benzadrine on fatigue in normal and neurotic persons . AMA Arch Neurol Psychiatry1936;36: 816-822.
72.
Kayton W., Raskind M.: Treatment of depression in the medically ill elderly with methylphenidate . Am J Psychiatry1980; 137:963-965.
73.
Hackett TP: The Use of Stimulant Drugs in General Hospital Psychiatry, tape. Glendale Calif, Audio-Digest Foundation , vol 7(12), 1978 .
74.
Kaufmann MW , Cassem NH, Murray GB, et al: Use of psychostimulants in medically ill patients with neurological disease and major depression. Can J Psychiatry1984;29:46-49.
75.
Woods SW, Tesar GE, Murray GB, et al: Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry1986 ;47:12-15.
76.
Forest WH: Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med1977;296:712-715.
77.
Silberman EK : Heterogeneity of amphetamine response in depressed patients. Am J Psychiatry1981;138:1302-1306.
78.
Holliday AR , Joffe JR: A controlled evaluation of protriptyline compared to placebo and to methylphenidate hydrochloride. J New Drugs1965;5:257.
79.
Kaplitz SE: Withdrawn, apathetic geriatric patients responsive to methylphenidate . J Am Geriatr Soc1975;23:271-276.
80.
Kaufmann MW , Murray GB, Cassem NH: Use of psychostimulants in medically ill depressed patients. Psychosomatics1982;23:817-819.
81.
Kaufmann MW : Use of methylphenidate in the elderly. Top Geriatr1982;1:3-4.
82.
Crook T, Cohen GD (eds): Physicians' Handbook on Psychotherapeutic Drug Use in the Aged. New Canaan, Conn, Mark Powley Associates, 1981.
83.
Brown WA: Psychologic and neuroendocrine responses to methylphenidate. Arch Gen Psychiatry1977;34:1103-1108.
84.
Wolf PA, Dawber TR, Thomas HE, et al: Epidemiology of stroke, in Thompson RA, Green JR (eds): Advances in Neurology. New York, Raven Press, 1977, pp 5-19.
85.
Robinson RG : Depression in aphasic patients: Frequency, severity, and clinicopathological correlations. Brain Lang1981;14:282-291.
86.
Lipsey JR, Pearlson GD, Robinson RG, et al: Nortriptyline treatment of post-stroke depression: A double-blind study. Lancet1984;1:297-300.
87.
Robinson RG , Szetela B.: Mood change following left hemisphere brain injury. Ann Neurol1981;9:447-453.
88.
Robinson RG , Kubos KL, Starr LB, et al: Mood changes in stroke patients: Relationship to lesion location. Compr Psychiatry1983;24:555-566.
89.
Snyder SH, Yamamura HI: Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry1977;34: 236-239.
90.
Veith RC, Raskind MA, Caldwell JH, et al: Cardiovascular effects of tricyclic antidepressants. N Engl J Med1982;306: 954-959.
91.
Glassman AH , Johnson LL, Giardina Egv, et al: The use of imipramine in depressed patients with congestive heart failure. JAMA1983;250:1997-2001.
92.
Rudorfer MV , Young RC: Desipramine: Cardiovascular effects and plasma levels. Am J Psychiatry1980;137:984-986.
93.
Gomoll AW, Byrne JE: Trazodone and imipramine: Comparative effects on canine cardiac conduction . Eur J Pharmacol1979; 57:335-342.
94.
Hayes RL, Gerner RH, Fairbanks L., et al: EKG findings in geriatric depressives given trazodone, placebo or imipramine. J Clin Psychiatry1983;44:180-183.
95.
Giardina E-GV , Bigger JT, Glassman AH, et al: The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation1979;60:1045-1052.
96.
Raskind M., Veith R., Barnes R., et al: Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease . Am J Psychiatry1982;139:1114-1117.
97.
Giardina Egv , Bigger JT, Johnson LL: The effect of imipramine and nortriptyline on ventricular premature depolarizations and left ventricular function. Circulation1981;64:316.
98.
Goff D., Jenike MA: Treatment resistant depression in the elderly. J Am Ger Soc1986;34:63-70.
99.
Roose SP, Glassman AH, Giardina Egv, et al: Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry1987 ;44:273-275.
100.
Biggs JT, Spiker DG, Petit JM, et al: Tricyclic antidepressant overdose. JAMA1977;238:135-138.
101.
Callahan M. : Tricyclic antidepressant overdose. JACEP1979;8: 413-425.
102.
Zavodnick S.: Atrial flutter with amoxapine: A case report . Am J Psychiatry1981;138:1503-1504.
103.
Wellens H. , Cats B., Durren D.: Symptomatic sinus node abnormalities following lithium carbonate therapy. Am J Med1975; 59:285-287.
104.
Wilson J., Kraus E.; Bailas M., et al: Reversible sinus node abnormalities due to lithium carbonate therapy. N Engl J Med1976;294:1223-1224.
105.
Jaffe CM: First-degree atrioventricular block during lithium carbonate treatment . Am J Psychiatry1977;134:88-89.
Goodwin FK , Prange AJ, Post RM, et al: Potentiation of antidepressant effects of L-triiodothyronine in tricyclic nonresponders . Am J Psychiatry1982;139:34-38.
108.
Earle BV: Thyroid hormone and tricyclic antidepressants in resistant depressions . Am J Psychiatry1970;126:1667-1669.
109.
Ogura C., Okuma T., Uchida Y., et al: Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states. Folia Psychiatr Neurol Jpn1974;28:179-186.
110.
Banki CM: Triiodothyronine in the treatment of depression. Prv Hetil1975;116:2543-2546.
111.
Banki CM: Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women. Eur J Pharmacol1977;11:311-315.
112.
Tsutsui S., Yamazaki Y., Namba T., et al: Combined therapy of T3 and antidepressants in depression . J Int Med Res1979;7: 138-146.
113.
Baldessarini RJ: A summary of biomedical aspects of mood disorders . McLean Hosp J 1981;6:1-34.
114.
Klein DF, Davis JM: Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore, Williams & Wilkins Co, 1969.
115.
Jenike MA: Electroconvulsive therapy. Top Geriatr1983 ;1: 37-38.
116.
Jenike MA: Electroconvulsive therapy: What are the facts? Geriatrics1984;38:33-38.
117.
Weiner RD: The role of electroconvulsive therapy in the treatment of depression in the elderly. J Am Geriatr Soc1982;30: 710-712.
118.
Electroconvulsive Therapy, American Psychiatric Association Task Force on ECT. Task force report No. 14. Washington, DC, American Psychiatric Association, 1978.
119.
Scovern AW , Kilmann PR: Status of ECT: A review of the outcome literature . Psychol Bull1980;87:260.
120.
Fink M.: Convulsive Therapy: Theory and Practice. New York , Raven Press, 1979.
121.
Hughes J., Barraclough BM, Reeve W.: Are patients shocked by ECT?J R Soc Med1981 ;74:283.
122.
Fraser RM, Glass IB: Recovery from ECT in elderly patients. Br J Psychiatry1978;133:524.
123.
Fraser RM, Glass IB: Unilateral and bilateral ECT in elderly patients. Acta Psychiatr Scand1980;62:13.